Rankings
▼
Calendar
NAUT Q4 2022 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
NAUT
Nautilus Biotechnology, Inc.
$339M
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$921,000
Operating Income
-$16M
Net Income
-$13M
EPS (Diluted)
$-0.11
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$11M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$350M
Total Liabilities
$35M
Stockholders' Equity
$315M
Cash & Equivalents
$115M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$921,000
-$263,000
-250.2%
Operating Income
-$16M
-$17M
+3.0%
Net Income
-$13M
-$17M
+19.7%
← FY 2022
All Quarters
Q1 2023 →